IMGN - ImmunoGen Inc.'s (IMGN) CEO Mark Enyedy on Q3 2021 Results - Earnings Call Transcript

ImmunoGen, Inc. (IMGN) Q3 2021 Earnings Conference Call October 29, 2021, 08:00 AM ET Company Participants Courtney O’Konek - Senior Director, Corporate Communications & IR Mark Enyedy - President and CEO Anna Berkenblit - SVP and Chief Medical Officer Susan Altschuller - SVP and CFO Conference Call Participants John Newman - Canaccord Genuity Michael Schmidt - Guggenheim Securities Andy Hsieh - William Blair & Company Kennan Mackay - RBC Capital Markets Kelly Shi - Jefferies Jonathan Chang - SVB Leerink RK Ramakanth - H.C. Wainwright Joseph Catanzaro - Piper Sandler Boris Peaker - Cowen Presentation Operator Good morning, and welcome to ImmunoGen's Third Quarter 2021 Financial and Operating Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Courtney O'Konek, Senior Director of Corporate Communications and Investor Relations. Please go ahead. Courtney O’Konek Good morning and thank you for joining today's

For further details see:

ImmunoGen, Inc.'s (IMGN) CEO Mark Enyedy on Q3 2021 Results - Earnings Call Transcript